Miller Vincent A. 4
4 · Revolution Medicines, Inc. · Filed Mar 24, 2021
Insider Transaction Report
Form 4
Miller Vincent A.
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-03-22−1,600→ 12,785 totalExercise: $4.73Exp: 2029-08-08→ Common Stock (1,600 underlying) - Exercise/Conversion
Common Stock
2021-03-22$4.73/sh+3,200$15,136→ 23,333 total - Sale
Common Stock
2021-03-22$49.00/sh−3,200$156,800→ 20,133 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-22−1,600→ 16,397 totalExercise: $4.73Exp: 2029-08-08→ Common Stock (1,600 underlying)
Footnotes (3)
- [F1]Includes 1,808 Restricted Stock Units.
- [F2]The option is early exercisable. One twenty-fourth (1/24th) of the shares initially subject to the option will vest on each monthly anniversary measured from August 9, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the second anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
- [F3]The option is early exercisable. One twelfth (1/12th) of the shares initially subject to the option will vest on each monthly anniversary measured from September 27, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.